Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Tang, G. Eslick, C. Nowson, Caroline Smith, A. Bensoussan (2007)
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysisThe Lancet, 370
Jessop Jd (1969)
Familial Mediterranean FeverJournal of the Royal Society of Medicine, 62
Y. Baykal, K. Sağlam, M. Yilmaz, A. Taşlıpınar, S. Akıncı, A. Inal (2003)
Serum sIL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients.Clinical rheumatology, 22 2
S. Ozen (2003)
Familial mediterranean fever: revisiting an ancient diseaseEuropean Journal of Pediatrics, 162
X. Deprez, P. Fardellone (2003)
Nonpharmacological prevention of osteoporotic fractures.Joint, bone, spine : revue du rhumatisme, 70 6
A. Kearns, S. Khosla, P. Kostenuik (2008)
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Endocrine reviews, 29 2
J. Clowes, B. Riggs, S. Khosla (2005)
The role of the immune system in the pathophysiology of osteoporosisImmunological Reviews, 208
M. McClung (2007)
Role of RANKL inhibition in osteoporosisArthritis Research & Therapy, 9
C. Derk (2006)
Osteoporosis in premenopausePostgraduate Medicine, 119
S. Köklü, M. Oztürk, M. Balcı, O. Yüksel, I. Ertenli, S. Kiraz (2005)
Interferon-gamma levels in familial Mediterranean fever.Joint, bone, spine : revue du rhumatisme, 72 1
X Deprez, P Fardellone (2003)
Nonpharmacological prevention of osteoporotic fracturesJt Bone Spine, 70
P. Miller (2007)
Guidelines for the diagnosis of osteoporosis: T-scores vs fracturesReviews in Endocrine and Metabolic Disorders, 7
H. Orbach, E. Ben-Chetrit (2001)
Familial mediterranean fever - a review and update.Minerva medica, 92 6
A. Duzova, F. Ozaltin, A. Ozon, N. Beşbaş, R. Topaloğlu, S. Ozen, Ayşin Bakkaloglu (2004)
Bone mineral density in children with familial Mediterranean feverClinical Rheumatology, 23
C. Kessenich (2007)
Nonpharmacological prevention of osteoporotic fracturesClinical Interventions in Aging, 2
S. Bağcı, B. Toy, A. Tuzun, Y. Ates, M. Aslan, A. Inal, M. Gulsen, N. Karaeren, K. Dağalp (2004)
Continuity of cytokine activation in patients with familial Mediterranean feverClinical Rheumatology, 23
A. Duzova, R. Topaloğlu, M. Keskin, U. Ozcelik, G. Seçmeer, A. Tokgozoglu (2004)
An unusual pattern of arthritis in a child with Kawasaki syndromeClinical Rheumatology, 23
(2008)
Tscores vs fractures
E. Romas, M. Gillespie, T. Martin (2002)
Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritisBone, 30
L. Raisz (1999)
Physiology and pathophysiology of bone remodeling.Clinical chemistry, 45 8 Pt 2
S Köklü, MA Öztürk, M Balcı (2005)
Interferon-gamma levels in familial Mediterranean feverJt Bone Spine, 72
Cengiz Korkmaz, H. Ozdogan, Ozgur Kasapcopur, Halil Yazici (2002)
Acute phase response in familial Mediterranean feverAnnals of the Rheumatic Diseases, 61
M. Tunca, G. Kirkali, M. Soytürk, S. Akar, M. Pepys, P. Hawkins (1999)
Acute phase response and evolution of familial Mediterranean fever.Lancet, 353 9162
Sakae Tanaka, Kozo Nakamura, N. Takahasi, T. Suda (2005)
Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL–RANK signaling systemImmunological Reviews, 208
Ş. Haznedaroğlu, M. Oztürk, B. Sancak, B. Goker, A. Onat, N. Bukan, I. Ertenli, S. Kiraz, M. Calguneri (2005)
Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever.Clinical and experimental rheumatology, 23 4 Suppl 38
L. Ginaldi, Maria Benedetto, M. Martinis (2005)
Osteoporosis, inflammation and ageingImmunity & ageing : I & A, 2
We investigated the association between familial Mediterranean fever (FMF) and osteoporosis (OP) in adult patients. Thirty-five attack-free FMF patients (28 females, 7 males; mean age 36.9 ± 5.7 years) were individually matched to control subjects on the basis of age (within 2 years) and sex. All patients were taking regular colchicine. Subjects having any condition that can cause decreased bone mineral density (BMD) were excluded from the study. BMD was measured at the spine and femur by dual X-ray absorptiometry (DXA). Data was given as the median (IQR). T scores of the spine were −0.700 (−1.097 to −0.262) and −0.450 (−0.830 to 0.112) in FMF patients and healthy controls, respectively (p > 0.05). T scores of the femur neck were −0.900 (−1.480 to −0.570) and −0.430 (−1.472 to 0.247) in FMF patients and healthy controls, respectively (p > 0.05). Total femur T scores were significantly lower in FMF patients than healthy controls (−0.780 [−1.222 to −0.085] vs. −0.100 [−0.765 to 0.537], respectively, p = 0.021). Total femur T scores were significantly decreased in adult patients with FMF. Ongoing subclinical inflammation may be associated with decreased bone mineral content in those patients.
Clinical Rheumatology – Springer Journals
Published: Jun 14, 2008
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.